http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003286188-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1010e3862914acdd087e73d76911ec6d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705440991e4945d742a59aec7396a403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b121aa9240dd513ee472baaeb5a11cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d2b360fc4db7894f22112153aacf3b |
| publicationDate | 2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003286188-A |
| titleOfInvention | Modulators of neurotrophin receptor-mediated signaling |
| abstract | (57) Abstract: The present invention is useful for regulating signal transduction via neurotrophin receptor p75, and useful for treating or preventing a disease caused by abnormal signal transduction via neurotrophin receptor p75. To provide appropriate means. A p75 NTR- mediated signaling modulator comprising as an active ingredient a polypeptide having SEQ ID NO: 2 or a derivative thereof; p75 comprising an antibody or a fragment thereof which specifically binds to the polypeptide as an active ingredient modulators of NTR-mediated signaling; the polypeptide active ingredient a nucleic acid encoding, modulators of p75 NTR mediated signaling; and antisense nucleic acids of the active ingredient of the nucleic acid, modulators of p75 NTR-mediated signaling; P7 containing the regulator as an active ingredient 5. A pharmaceutical composition for treating or preventing a disease caused by abnormal NTR- mediated signal transduction. |
| priorityDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 568.